Xuejun Li Selected Research

Muscular Atrophy (Muscle Atrophy)

1/2020	Physiological Ca2+ Transients Versus Pathological Steady-State Ca2+ Elevation, Who Flips the ROS Coin in Skeletal Muscle Mitochondria.
10/2017	Absence of physiological Ca2+ transients is an initial trigger for mitochondrial dysfunction in skeletal muscle following denervation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xuejun Li Research Topics

Disease

66	Neoplasms (Cancer) 05/2024 - 09/2010
24	Glioma (Gliomas) 05/2024 - 01/2014
15	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 08/2013
14	Type 2 Diabetes Mellitus (MODY) 12/2023 - 11/2015
11	Inflammation (Inflammations) 04/2024 - 04/2010
11	Non-alcoholic Fatty Liver Disease 01/2023 - 01/2013
9	Insulin Resistance 01/2022 - 01/2013
8	Obesity 04/2024 - 02/2016
8	Hypoxia (Hypoxemia) 04/2024 - 01/2008
8	Infections 06/2022 - 12/2014
8	Pituitary Neoplasms (Pituitary Adenoma) 03/2021 - 08/2014
8	Ischemia 10/2019 - 01/2008
7	Brain Neoplasms (Brain Tumor) 04/2024 - 10/2011
7	Mitochondrial Diseases (Mitochondrial Disease) 02/2022 - 06/2012
7	Body Weight (Weight, Body) 01/2021 - 11/2006
6	Wounds and Injuries (Trauma) 04/2024 - 01/2013
6	Lung Neoplasms (Lung Cancer) 01/2023 - 02/2012
4	Hypersensitivity (Allergy) 04/2024 - 10/2018
4	Obstructive Sleep Apnea 04/2024 - 01/2019
4	Pain (Aches) 03/2024 - 01/2014
4	Hypoglycemia (Reactive Hypoglycemia) 12/2023 - 11/2015
4	Fibrosis (Cirrhosis) 01/2023 - 09/2002
4	Hypertension (High Blood Pressure) 01/2023 - 01/2014
4	Adenocarcinoma of Lung 01/2023 - 06/2008
4	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2019
4	Neoplasm Metastasis (Metastasis) 12/2016 - 10/2011
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015 - 02/2012
3	Hypertrophy 04/2024 - 12/2008
3	Liver Cirrhosis (Hepatic Cirrhosis) 02/2023 - 10/2021
3	Medulloblastoma 01/2023 - 01/2020
3	Reperfusion Injury 02/2022 - 01/2018
3	Carcinogenesis 01/2022 - 01/2019
3	Chronic Hepatitis B 10/2021 - 01/2013
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 01/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 12/2012
3	Cysts 01/2019 - 03/2011
3	Carcinoma (Carcinomatosis) 03/2016 - 05/2012
2	Melanoma (Melanoma, Malignant) 01/2024 - 01/2021
2	Dysbiosis 01/2023 - 12/2021
2	Myocardial Infarction 01/2023 - 01/2018
2	Ulcerative Colitis 01/2023 - 01/2021
2	Disease Resistance 02/2022 - 01/2021
2	Disease Progression 01/2022 - 09/2021

Drug/Important Bio-Agent (IBA)

18	Biomarkers (Surrogate Marker)IBA 03/2024 - 10/2011
18	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2008
15	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 01/2008
13	RNA (Ribonucleic Acid)IBA 01/2023 - 09/2010
11	Insulin (Novolin)FDA Link 01/2022 - 01/2016
10	LipidsIBA 05/2024 - 01/2013
6	Fetuin-BIBA 01/2022 - 12/2017
5	Therapeutic UsesIBA 01/2024 - 01/2017
5	ORALIT (ORS)IBA 01/2022 - 02/2015
5	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2016
5	CurcuminIBA 01/2020 - 03/2011
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 02/2012
5	MicroRNAs (MicroRNA)IBA 01/2019 - 09/2010
4	Blood Glucose (Blood Sugar)IBA 12/2023 - 01/2013
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 02/2012
4	Uric Acid (Urate)IBA 01/2019 - 12/2016
4	Leukocyte Elastase (Neutrophil Elastase)IBA 05/2017 - 08/2012
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2014 - 01/2012
3	Hormones (Hormone)IBA 04/2024 - 06/2015
3	Interleukin-6 (Interleukin 6)IBA 04/2024 - 10/2017
3	Small Cytoplasmic RNAIBA 03/2024 - 01/2021
3	Peptides (Polypeptides)IBA 10/2023 - 05/2012
3	CateninsIBA 01/2023 - 01/2017
3	Caspase 3 (Caspase-3)IBA 01/2023 - 01/2018
3	Ion Channels (Ion Channel)IBA 01/2023 - 11/2018
3	Messenger RNA (mRNA)IBA 01/2022 - 11/2006
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021 - 10/2019
3	ParaffinIBA 01/2020 - 09/2010
3	Oxygen (Dioxygen)IBA 09/2019 - 01/2008
3	Temozolomide (Temodar)FDA LinkGeneric 01/2019 - 01/2017
3	puerarinIBA 01/2018 - 01/2014
3	Alanine Transaminase (SGPT)IBA 01/2018 - 10/2015
3	LDL CholesterolIBA 01/2018 - 12/2012
3	HDL CholesterolIBA 01/2018 - 12/2012
3	CytokinesIBA 05/2017 - 04/2010
3	Atorvastatin (Lipitor)FDA Link 05/2012 - 02/2012
2	Oxidoreductases (Dehydrogenase)IBA 05/2024 - 01/2018
2	EnzymesIBA 05/2024 - 01/2018
2	LipopolysaccharidesIBA 04/2024 - 10/2017
2	Capsules (Microcapsules)IBA 01/2024 - 08/2022
2	Abscisic AcidIBA 11/2023 - 11/2022
2	CalciumIBA 10/2023 - 01/2023
2	Protein Isoforms (Isoforms)IBA 10/2023 - 01/2018
2	Potassium Channels (Potassium Channel)IBA 10/2023 - 01/2020
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 06/2023 - 01/2018
2	CollagenIBA 02/2023 - 09/2002
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2021
2	Triiodothyronine (Liothyronine)FDA LinkGeneric 12/2022 - 01/2022
2	Estrogen ReceptorsIBA 01/2022 - 06/2012
2	AcidsIBA 01/2022 - 11/2020

Therapy/Procedure

18	Therapeutics 11/2023 - 01/2013
11	Radiotherapy 04/2024 - 06/2012
11	Drug Therapy (Chemotherapy) 01/2023 - 05/2012
8	Immunotherapy 01/2024 - 01/2021
5	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2024 - 01/2013
3	Chemoradiotherapy 11/2023 - 09/2017
2	Fecal Microbiota Transplantation 01/2023 - 01/2021